BiomX Inc. (PHGE) Stock Forecast
PHGE analyst forecast
as of October 16, 2026- Analyst consensus
- Buy 4.00 / 5 from 2 analysts
- Price target
- $304.00 average of analyst targets
- Upside to target
- +104,188.2% from the latest close
- Next earnings
- —
- 52-week range
- $0.29 – $112.82
PHGE analyst ratings
2 analystsNumber of analysts at each rating.
PHGE price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
PHGE earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current fiscal year (2026) | −$58.50 | −$58.50 | −$58.50 | −$221.90 | +73.6% | 1 |
| Next fiscal year (2027) | −$60.10 | −$60.10 | −$60.10 | −$58.50 | −2.7% | 1 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
PHGE revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current fiscal year (2026) | $0 | $0 | $0 | 0.0% | — |
| Next fiscal year (2027) | $0 | $0 | $0 | 0.0% | 1 |
PHGE EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
PHGE EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current fiscal year (2026) | −$122.35 | −$58.50 | −$58.50 | −$58.50 | −$58.50 | −52.2% | 0 up · 0 down |
| Next fiscal year (2027) | −$129.80 | −$129.80 | −$129.80 | −$129.80 | −$60.10 | −53.7% | 1 up · 1 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
PHGE earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; PHGE beat in 7 of 10.
What analysts expect from PHGE
2 analysts cover BiomX; their consensus rating is buy (4.00 on a 1–5 scale, where 5 is a strong buy). The average price target is $304.00, 104,188.2% above the latest close of $0.29. Analysts expect earnings of −$58.50 per share for 2026, +73.6% from a year earlier. For 2027 the average estimate is −$60.10 per share. BiomX beat the EPS estimate in 7 of the last 10 quarters.
Related: PHGE income statement, PHGE key metrics, PHGE chart. See the PHGE stock overview for the latest quote and news.
PHGE forecast FAQ
What is BiomX's price target?
The average analyst price target for BiomX is $304.00, 104,188.2% above the latest close of $0.29.
Is BiomX a buy, hold or sell?
Of 2 analysts covering BiomX, 0 rate it a strong buy, 2 a buy, 0 a hold, 0 a sell and 0 a strong sell, a consensus of buy. Ratings are opinions, not a recommendation from Quotelinks.
What is BiomX's EPS forecast?
Analysts forecast −$58.50 per share for 2026 (range −$58.50 to −$58.50); for 2027 the estimate is −$60.10.
Does BiomX usually beat earnings estimates?
BiomX reported EPS at or above the analyst estimate in 7 of the last 10 quarters.